Medical bioremediation of age-related diseases

Jacques M Mathieu1, John Schloendorn, Bruce E Rittmann

  • 1Dept, of Civil and Environmental Engineering, Rice University, Houston, TX, USA. mathieu@rice.edu.

Insights

Medical bioremediation uses microbial enzymes to remove harmful compounds that accumulate in aging and cause diseases like Alzheimer's. This approach offers a promising alternative to traditional therapies for age-related conditions.

Area of Science:

  • Biochemistry
  • Microbiology
  • Biotechnology

Background:

  • Catabolic insufficiency in humans causes pathogenic compound accumulation, linked to age-related diseases such as atherosclerosis and Alzheimer's disease.
  • Current therapeutic strategies, including antibodies and endogenous human enzymes, have shown limited efficacy and potential risks to cellular homeostasis.
  • Medical bioremediation presents an alternative strategy by leveraging microbial enzymes to restore catabolic functions.

Purpose of the Study:

  • This review explores the potential of medical bioremediation for treating age-related diseases.
  • It identifies specific targets for biodegradation and suitable microbial enzymes.
  • The review also discusses effective enzyme delivery methods for therapeutic applications.

Main Methods:

  • The review synthesizes existing research on catabolic pathways and age-related disease mechanisms.
  • It analyzes the microbial genetic diversity for identifying enzymes with specific degradation capabilities.
  • Methods for enzyme delivery, including potential delivery vectors and strategies, are discussed.

Main Results:

  • Microbial enzymes offer a diverse enzymatic toolkit for degrading a wide range of organic compounds.
  • Specific microbial enzymes can be identified and engineered to target pathogenic compounds associated with age-related diseases.
  • Various enzyme delivery systems are being explored to ensure targeted and effective delivery within the human body.

Conclusions:

  • Medical bioremediation, utilizing microbial enzymes, represents a promising therapeutic avenue for managing age-related diseases.
  • Further research into enzyme discovery, engineering, and delivery systems is crucial for clinical translation.
  • This approach holds potential for augmenting human catabolic functions and mitigating disease progression.

Related Concept Videos

Bioremediation00:46

Bioremediation

Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
Microbial Bioremediation of Hydrocarbons01:26

Microbial Bioremediation of Hydrocarbons

Bioremediation is an environmentally sustainable process that employs living organisms—primarily microorganisms—to degrade or neutralize pollutants from contaminated environments. In oil spills and hydrocarbon pollution, bioremediation involves the use of hydrocarbon-degrading bacteria to transform toxic compounds into less harmful substances. This approach leverages natural microbial metabolic processes and is considered both cost-effective and ecologically favorable compared to physical or...
Microbial Bioremediation of Pesticides01:28

Microbial Bioremediation of Pesticides

Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
Microbial Bioremediation of Uranium01:25

Microbial Bioremediation of Uranium

Microorganisms play a critical role in the transformation and immobilization of uranium in contaminated environments through four main pathways: bioreduction, biosorption, bioaccumulation, and biomineralization. These mechanisms reduce uranium’s toxicity and prevent its migration through groundwater systems, offering sustainable approaches for in situ bioremediation.Bioreduction of UraniumBioreduction is driven by anaerobic bacteria such as certain strains of Geobacter and Shewanella, which use...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...